What do healthcare teams get wrong about post-SOC 2 compliance planning?

Why healthcare teams misread SOC 2 as a finish line

For healthcare organisations, SOC 2 can become a false stopping point because it certifies a control environment, not the clinical or regulatory reality of handling protected health information. The mistake is assuming that a clean SOC 2 report means the organisation is ready for HIPAA-aligned operations or for a buyer-driven framework such as HITRUST. That shortcut can leave gaps in privacy, data handling, and scope definition that matter far more than the audit badge. The better comparison is not “SOC 2 versus HITRUST” but “what do our actual data flows require?” The broader control baseline described in the NIST Cybersecurity Framework 2.0 is useful here because it encourages teams to think about governance, protection, detection, and recovery as an operating model rather than a single certification event. In practice, many healthcare teams discover the gap only after a customer, auditor, or privacy review asks whether PHI was ever validated in scope at all.

How post-SOC 2 planning should actually be sequenced

Post-SOC 2 planning works best when teams treat SOC 2 as evidence about some controls, not proof that the whole compliance problem is solved. The first job is to determine whether the organisation truly handles PHI, where that PHI lives, who touches it, and which workflows create regulated exposure. Only then can the team decide whether HIPAA mapping, business associate obligations, privacy safeguards, and buyer-requested attestations such as HITRUST are appropriate. If that scoping is done backwards, teams spend time hardening controls that do not address the real data path or the real contract obligation.

A practical sequence is:

• Map systems, integrations, and users to actual PHI handling rather than to assumed business functions.
• Compare existing SOC 2 controls to the healthcare-specific requirements that matter for the intended service model.
• Identify where policy exists but operational evidence does not, especially around access, retention, logging, and incident response.
• Use the results to decide whether the next step is HIPAA remediation, buyer-specific evidence packaging, or a narrower certification scope.

Teams often need the broader control detail in NIST SP 800-53 Rev 5 Security and Privacy Controls because it helps translate abstract compliance expectations into concrete safeguards and evidence types. This guidance breaks down when organisations skip data-flow validation and try to treat certification choice as a substitute for regulatory scoping.

Where the post-SOC 2 path gets distorted

Tighter assurance planning often increases assessment overhead, requiring organisations to balance buyer expectations against the cost of over-scoping controls. The main distortion is that teams try to satisfy every possible framework at once, even when the business only needs to prove a smaller and more accurate set of controls. That creates two common edge cases.

First, some organisations do not process PHI in the way their sales or procurement narratives imply. In that case, the right move is usually to correct the claim, not to expand the control programme unnecessarily. Second, some teams do handle PHI but only through limited workflows or vendors. Here, the compliance boundary should be narrowed to the real processing path, because overbroad scoping can waste effort and make evidence harder to maintain.

There is also an unresolved industry reality: buyers often ask for HITRUST because it is familiar, even when the underlying requirement is simply proof of HIPAA-relevant controls. That is a commercial demand issue, not a control-design principle. The best practice is to separate contractual demand from actual regulatory obligation and then decide whether a larger assurance package is truly justified. Healthcare teams that ignore that distinction often end up with overlapping documents, duplicated control narratives, and a compliance programme that looks stronger than it is.

Practitioner Guidance

What to prioritise: Validate whether PHI is actually in scope before choosing the next assurance target. If the answer is unclear, resolve the data classification and workflow mapping first, because every downstream control decision depends on it.

Decision rule: If the organisation can show SOC 2 controls but cannot show how those controls map to healthcare handling requirements, treat the gap as a scoping and evidence problem, not as a reason to add another certificate.

What to verify: Confirm that privacy, access, logging, retention, incident response, and vendor oversight are evidenced in the same operational paths that handle regulated data. A policy set is not enough if the actual system boundaries differ.

Practitioner takeaway: The strongest post-SOC 2 plan is usually the narrowest one that correctly matches the data, the contracts, and the healthcare obligation; anything broader risks creating expensive compliance theatre.

Related resources from NHI Mgmt Group

• What do security teams get wrong about access compliance in healthcare?
• What do security teams get wrong about SLA compliance in SOC operations?
• What do compliance teams get wrong about using industry webinars for regulatory planning?
• What do security teams get wrong about healthcare chatbot governance?